About Galderma Pharma
Founded in 1981 as a joint venture between Nestle and L'Oreal, Galderma is a fully integrated specialized pharmaceutical company operating exclusively in dermatology. The company is present in 65 countries with over 1000 sales representatives and is committed to improving skin health with a comprehensive range of products to treat several skin conditions such as: Acne, Rosacea, Mycotic Nail Infections, Psoriasis & Steroid Responsive Dermatosis, Pigmentation Disorders, Medical Solutions for Skin Senescence and Skin Cancer. With a new research and development (R&D) center in Sophia Antipolis (France), Galderma has one of the largest R&D facilities dedicated exclusively to dermatology. Leading dermatology brands include Differin(R), Metrogel(R) 1%/Rozex(R), Clobex(R), Tri-Luma(R), Loceryl(R) and Cetaphil(R). Recently launched products include Pliaglis(TM), an external anesthetic for dermatologic treatments in the US, Epiduo(R), an innovative combination product for the treatment of acne in Europe and Argentina, and Dysport(R), an injectable neuromodulator for the correction of wrinkles in Brazil and Argentina.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Advertisement
